The Childrens Hospital at Montefiore Albert Einstein School of Medicine
Welcome,         Profile    Billing    Logout  
 1 Trial 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nguyen, Trang
HPV9vxFSW, NCT06681636: Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure

Not yet recruiting
2
300
RoW
Human papillomavirus 9-valent vaccine, Recombinant, Gardasil 9
National Institute of Hygiene and Epidemiology, Vietnam, Murdoch Childrens Research Institute, CENTER FOR SUPPORTING COMMUNITY DEVELOPMENT INITIATIVES, Hai phong Center for Disease Control
HPV Infection, Cervical Cancer, Anogenital Cancer, Anogenital Warts
10/26
12/27
NCT06057935: A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

Recruiting
2
64
US
Pemetrexed, Cisplatin, Carboplatin
Memorial Sloan Kettering Cancer Center
Malignant Peritoneal Mesothelioma, Peritoneal Mesothelioma, Mesothelioma, Mesothelioma, Malignant, Malignant Mesothelioma
09/28
09/28
Ovchinsky, Nadia
ASSERT-EXT, NCT05035030 / 2021-000996-36: Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome

Recruiting
3
70
Europe, US, RoW
Odevixibat, A4250
Albireo, an Ipsen Company
Alagille Syndrome
10/26
04/27
BOLD, NCT04336722 / 2019-003807-37: Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE

Active, not recruiting
3
254
Europe, Canada, US, RoW
Odevixibat, Placebo
Albireo, an Ipsen Company
Biliary Atresia
06/26
07/26
NCT03115086: The REPLACE Registry for Cholbam® (Cholic Acid)

Active, not recruiting
N/A
55
US
Cholbam
Mirum Pharmaceuticals, Inc.
Bile Acid Synthesis Disorders
07/38
07/39
Lee, Way Seah
ASSERT-EXT, NCT05035030 / 2021-000996-36: Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome

Recruiting
3
70
Europe, US, RoW
Odevixibat, A4250
Albireo, an Ipsen Company
Alagille Syndrome
10/26
04/27
BOLD, NCT04336722 / 2019-003807-37: Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE

Active, not recruiting
3
254
Europe, Canada, US, RoW
Odevixibat, Placebo
Albireo, an Ipsen Company
Biliary Atresia
06/26
07/26
Leary, Megan
No trials found

Download Options